VERU Veru posts narrower Q1 2026 loss than analyst forecasts shares dip 218 percent in todays trading ELA Envela Corporation blows past Q4 2025 EPS estimates notches a 108 percent share gain in todays trading The TJX Companies Inc TJX Peer OffPrice Retailer Ollies Bargain Outlet OLLI Draws Bullish Rating Amid Valuation Reset The structural growth drivers for Hancock HWC On the Radar 20260508 Economic Policy Institute Releases Latest JobsDay Analysis Highlighting Labor Market Trends Barnes Noble CEO James Daunt Clarifies Stance on AIGenerated Books A Straightforward Rejection of AI Books EU Considers Trade Defense Tools Amid Looming China Trade War AI Wealth Must Serve Public Good South Koreas Deputy PM Warns Amid Samsung Labor Unrest Ryanair Reports Record Annual Profit of 226 Billion Up 40 Despite Boeing Delays and Fuel Market Uncertainty Treasury Bond Ladder Strategy Offers Retirees Predictable Income Amid Yield Gap Insperity Inc NSP Q1 2026 Earnings EPS Beat Drives Positive Market Response Cibus Inc Q1 2026 Earnings Narrowed Loss Surprises Estimates Amid PreRevenue Progress NXST Q1 2026 Earnings Strong EPS Beat Amidst Modest Stock Decline as Nexstar Outperforms Estimates MSEX Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures Stock Edges Higher ACR Q1 2026 Earnings EPS Misses Estimates Amid Challenging Commercial Real Estate Environment SEE Q4 2025 Earnings EPS Surpasses Estimates by 43 Revenue Details Remain Undisclosed Vera Therapeutics VERA Consolidates Near Support After Slight Decline Lithium Americas Corp LAC Rises 246 as It Approaches Key Resistance Near 524 Plumas Bancorp PLBC Edges Higher Testing Key Resistance After Modest Gain SVAQU Remains Flat at 1005 as SPAC Units Trade in Tight Range Federal Agricultural Mortgage Corporation AGM Shows Modest Gain Amid Steady Support Levels Ral Castro Indictment Sparks Mixed Reactions Among CubanAmerican Community Geopolitical Tensions Could Affect CubaRelated Investments Supernus Pharmaceuticals SUPN Q1 2026 Earnings EPS Surges Past Expectations but Stock Retreats Olema Pharmaceuticals OLMA Tests Key Support Amid Broad Market Pressure